• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRKAR1A失活导致人B淋巴细胞增殖增加和凋亡减少。

PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes.

作者信息

Robinson-White Audrey J, Leitner Wolfgang W, Aleem Eiman, Kaldis Philipp, Bossis Ioannis, Stratakis Constantine A

机构信息

Section on Endocrinology and Genetics, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, NIH, Bethesda, Maryland 20892, USA.

出版信息

Cancer Res. 2006 Nov 1;66(21):10603-12. doi: 10.1158/0008-5472.CAN-06-2200.

DOI:10.1158/0008-5472.CAN-06-2200
PMID:17079485
Abstract

The multiple neoplasia syndrome Carney complex (CNC) is caused by heterozygote mutations in the gene, which codes for the RIalpha regulatory subunit (PRKAR1A) of protein kinase A. Inactivation of PRKAR1A and the additional loss of the normal allele lead to tumors in CNC patients and increased cyclic AMP signaling in their cells, but the oncogenetic mechanisms in affected tissues remain unknown. Previous studies suggested that PRKAR1A down-regulation may lead to increased mitogen-activated protein kinase (MAPK) signaling. Here, we show that, in lymphocytes with PRKAR1A-inactivating mutations, there is increased extracellular signal-regulated kinase (ERK) 1/2 and B-raf phosphorylation and MAPK/ERK kinase 1/2 and c-Myc activation, whereas c-Raf-1 is inhibited. These changes are accompanied by increased cell cycle rates and decreased apoptosis that result in an overall net gain in proliferation and survival. In conclusion, inactivation of PRKAR1A leads to widespread changes in molecular pathways that control cell cycle and apoptosis. This is the first study to show that human cells with partially inactivated RIalpha levels have increased proliferation and survival, suggesting that loss of the normal allele in these cells is not necessary for these changes to occur.

摘要

多发性肿瘤综合征卡尼复合征(CNC)由该基因的杂合突变引起,该基因编码蛋白激酶A的RIα调节亚基(PRKAR1A)。PRKAR1A的失活以及正常等位基因的额外缺失导致CNC患者发生肿瘤,并使其细胞中的环磷酸腺苷信号增加,但受影响组织中的致癌机制仍不清楚。先前的研究表明,PRKAR1A的下调可能导致丝裂原活化蛋白激酶(MAPK)信号增加。在此,我们表明,在具有PRKAR1A失活突变的淋巴细胞中,细胞外信号调节激酶(ERK)1/2和B-raf的磷酸化增加,MAPK/ERK激酶1/2和c-Myc被激活,而c-Raf-1受到抑制。这些变化伴随着细胞周期速率的增加和凋亡的减少,从而导致增殖和存活的总体净增加。总之,PRKAR1A的失活导致控制细胞周期和凋亡的分子途径发生广泛变化。这是第一项表明RIα水平部分失活的人类细胞增殖和存活增加的研究,表明这些细胞中正常等位基因的缺失对于这些变化的发生不是必需的。

相似文献

1
PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes.PRKAR1A失活导致人B淋巴细胞增殖增加和凋亡减少。
Cancer Res. 2006 Nov 1;66(21):10603-12. doi: 10.1158/0008-5472.CAN-06-2200.
2
PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.PRKAR1A突变以及蛋白激酶A与肾上腺皮质中其他信号通路的相互作用。
J Clin Endocrinol Metab. 2006 Jun;91(6):2380-8. doi: 10.1210/jc.2006-0188. Epub 2006 Mar 28.
3
Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2.PRKAR1A 突变细胞中的蛋白激酶 A 活性以及丝裂原活化蛋白激酶 ERK1/2 的调节
Hum Mol Genet. 2003 Jul 1;12(13):1475-84. doi: 10.1093/hmg/ddg160.
4
Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.卡尼复合症候群基因1(蛋白激酶A调节亚基1A)失活可抑制肾上腺皮质细胞中SMAD3的表达及转化生长因子β刺激的细胞凋亡。
Cancer Res. 2009 Sep 15;69(18):7278-84. doi: 10.1158/0008-5472.CAN-09-1601. Epub 2009 Sep 8.
5
Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells.PRKAR1A和PRKAR2B基因敲低对肾上腺皮质细胞信号通路、细胞生长及细胞周期调控影响的比较
Horm Metab Res. 2014 Nov;46(12):883-8. doi: 10.1055/s-0034-1389951. Epub 2014 Sep 30.
6
8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors.8-氯腺苷通过蛋白激酶A依赖性和非依赖性作用抑制B淋巴细胞增殖并诱导其凋亡:对卡尼综合征相关肿瘤治疗的意义。
J Clin Endocrinol Metab. 2009 Oct;94(10):4061-9. doi: 10.1210/jc.2009-0759. Epub 2009 Sep 22.
7
A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.携带蛋白激酶A调节亚基1A反义构建体的转基因小鼠发生内分泌及其他肿瘤:与卡尼综合征及其他PRKAR1A诱导性病变的比较
J Med Genet. 2004 Dec;41(12):923-31. doi: 10.1136/jmg.2004.028043.
8
Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.蛋白激酶A的调节亚基I-α(PRKAR1A):一种散发性甲状腺癌的肿瘤抑制基因。
Genes Chromosomes Cancer. 2002 Oct;35(2):182-92. doi: 10.1002/gcc.10112.
9
Minireview: PRKAR1A: normal and abnormal functions.综述:PRKAR1A:正常与异常功能
Endocrinology. 2004 Dec;145(12):5452-8. doi: 10.1210/en.2004-0900. Epub 2004 Aug 26.
10
Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas.牙源性黏液瘤中蛋白激酶A调节亚基1A(PRKAR1A)的分子和免疫组织化学研究
Genes Chromosomes Cancer. 2005 Oct;44(2):204-11. doi: 10.1002/gcc.20232.

引用本文的文献

1
Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient.单细胞测序揭示化疗对复发性卵巢癌患者免疫图谱和 TCR/BCR 克隆扩增的影响。
Front Immunol. 2022 Sep 28;13:985187. doi: 10.3389/fimmu.2022.985187. eCollection 2022.
2
Identification of contributing genes of Huntington's disease by machine learning.通过机器学习鉴定亨廷顿病的致病基因。
BMC Med Genomics. 2020 Nov 23;13(1):176. doi: 10.1186/s12920-020-00822-w.
3
Inflammation and Metabolism in Cancer Cell-Mitochondria Key Player.
癌细胞线粒体中的炎症与代谢:关键因素
Front Oncol. 2019 May 14;9:348. doi: 10.3389/fonc.2019.00348. eCollection 2019.
4
Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is.BRD4-NUT 依赖性 NUT 中线癌的遗传修饰物揭示 BETi 和 CDK4/6i 之间的协同作用。
Genes Dev. 2018 Sep 1;32(17-18):1188-1200. doi: 10.1101/gad.315648.118. Epub 2018 Aug 22.
5
Hematopoietic neoplasms in Prkar2a-deficient mice.Prkar2a基因缺陷小鼠中的造血系统肿瘤
J Exp Clin Cancer Res. 2015 Nov 25;34:143. doi: 10.1186/s13046-015-0257-z.
6
Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors.牙源性肿瘤中卡尼复合症基因(PRKAR1A)的缺陷。
Endocr Relat Cancer. 2015 Jun;22(3):399-408. doi: 10.1530/ERC-15-0094. Epub 2015 Apr 13.
7
MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.多发性内分泌腺瘤1型、多发性内分泌腺瘤4型与卡尼综合征:病理学与分子遗传学
Neuroendocrinology. 2016;103(1):18-31. doi: 10.1159/000371819. Epub 2015 Jan 9.
8
Loss of Prkar1a leads to Bcl-2 family protein induction and cachexia in mice.Prkar1a缺失导致小鼠体内Bcl-2家族蛋白的诱导和恶病质。
Cell Death Differ. 2014 Nov;21(11):1815-24. doi: 10.1038/cdd.2014.98. Epub 2014 Jul 11.
9
Inactivation of the Carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: a study using genetically encoded FRET-based reporters.卡尼复合征基因1(PRKAR1A)的失活改变了环磷酸腺苷(cAMP)和cAMP依赖性蛋白激酶的时空调节:一项使用基于荧光共振能量转移(FRET)的基因编码报告基因的研究。
Hum Mol Genet. 2014 Mar 1;23(5):1163-74. doi: 10.1093/hmg/ddt510. Epub 2013 Oct 10.
10
cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.肿瘤中 cAMP/PKA 信号缺陷:人类和小鼠中的遗传学和组织特异性多能细胞衍生损伤。
Mol Cell Endocrinol. 2013 May 22;371(1-2):208-20. doi: 10.1016/j.mce.2013.01.015. Epub 2013 Feb 26.